{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:11:57Z","timestamp":1772820717527,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1038\/80466","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"1128-1133","source":"Crossref","is-referenced-by-count":145,"title":["Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)"],"prefix":"10.1038","volume":"6","author":[{"given":"Stefan J.","family":"Ries","sequence":"first","affiliation":[]},{"given":"Christian H.","family":"Brandts","sequence":"additional","affiliation":[]},{"given":"Alicia S.","family":"Chung","sequence":"additional","affiliation":[]},{"given":"Carola H.","family":"Biederer","sequence":"additional","affiliation":[]},{"given":"Byron C.","family":"Hann","sequence":"additional","affiliation":[]},{"given":"Ettie M.","family":"Lipner","sequence":"additional","affiliation":[]},{"given":"Frank","family":"McCormick","sequence":"additional","affiliation":[]},{"given":"W.","family":"Michael Korn","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm1000_1128_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1126\/science.2889267","volume":"238","author":"ER Fearon","year":"1987","unstructured":"Fearon, E.R., Hamilton, S.R. & Vogelstein, B. Clonal analysis of human colorectal tumors. Science 238, 193\u2013197 (1987).","journal-title":"Science"},{"key":"BFnm1000_1128_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1200\/JCO.1995.13.4.1009","volume":"13","author":"F Chang","year":"1995","unstructured":"Chang, F., Syrjanen, S. & Syrjanen, K. Implications of the p53 tumor-suppressor gene in clinical oncology. J. Clin. Oncol. 13, 1009\u20131022 (1995).","journal-title":"J. Clin. Oncol."},{"key":"BFnm1000_1128_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.7973635","volume":"266","author":"SW Lowe","year":"1994","unstructured":"Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807\u2013810 (1994).","journal-title":"Science"},{"key":"BFnm1000_1128_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1095-1029","volume":"1","author":"J Bergh","year":"1995","unstructured":"Bergh, J., Norberg, T., Sjogren, S., Lindgren, A. & Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Med. 1, 1029\u20131034 (1995).","journal-title":"Nature Med."},{"key":"BFnm1000_1128_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","volume":"156","author":"DD Barker","year":"1987","unstructured":"Barker, D.D. & Berk, A.J. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156, 107\u2013121 (1987).","journal-title":"Virology"},{"key":"BFnm1000_1128_CR6","first-page":"798","volume":"6","author":"I Ganly","year":"2000","unstructured":"Ganly, I. et al. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin. Cancer Res. 6, 798\u2013806 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1000_1128_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"FR Khuri","year":"2000","unstructured":"Khuri, F.R. et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879\u2013885 (2000).","journal-title":"Nature Med."},{"key":"BFnm1000_1128_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nm0697-639","volume":"3","author":"C Heise","year":"1997","unstructured":"Heise, C. et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3, 639\u2013645 (1997).","journal-title":"Nature Med."},{"key":"BFnm1000_1128_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff, J.R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373\u2013376 (1996).","journal-title":"Science"},{"key":"BFnm1000_1128_CR10","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1128\/JVI.72.12.9479-9490.1998","volume":"72","author":"FD Goodrum","year":"1998","unstructured":"Goodrum, F.D. & Ornelles, D.A. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J. Virol. 72, 9479\u20139490 (1998).","journal-title":"J. Virol."},{"key":"BFnm1000_1128_CR11","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/JVI.73.3.2074-2083.1999","volume":"73","author":"AS Turnell","year":"1999","unstructured":"Turnell, A.S., Grand, R.J. & Gallimore, P.H. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status. J. Virol. 73, 2074\u20132083 (1999).","journal-title":"J. Virol."},{"key":"BFnm1000_1128_CR12","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","volume":"72","author":"T Rothmann","year":"1998","unstructured":"Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M. & zur Hausen, H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470\u20139478 (1998).","journal-title":"J. Virol."},{"key":"BFnm1000_1128_CR13","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1128\/JVI.73.7.5333-5344.1999","volume":"73","author":"JN Harada","year":"1999","unstructured":"Harada, J.N. & Berk, A.J. p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 73, 5333\u20135344 (1999).","journal-title":"J. Virol."},{"key":"BFnm1000_1128_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.onc.1201432","volume":"15","author":"J Piette","year":"1997","unstructured":"Piette, J., Neel, H. & Marechal, V. Mdm2: keeping p53 under control. Oncogene 15, 1001\u20131010 (1997).","journal-title":"Oncogene"},{"key":"BFnm1000_1128_CR15","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1073\/pnas.95.14.8292","volume":"95","author":"T Kamijo","year":"1998","unstructured":"Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292\u20138297 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1000_1128_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713\u2013723 (1998).","journal-title":"Cell"},{"key":"BFnm1000_1128_CR17","first-page":"5187","volume":"55","author":"T Waldman","year":"1995","unstructured":"Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187\u20135190 (1995).","journal-title":"Cancer Res."},{"key":"BFnm1000_1128_CR18","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","volume":"282","author":"F Bunz","year":"1998","unstructured":"Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497\u20131501 (1998).","journal-title":"Science"},{"key":"BFnm1000_1128_CR19","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1101\/gad.8.21.2540","volume":"8","author":"A Di Leonardo","year":"1994","unstructured":"Di Leonardo, A., Linke, S.P., Clarkin, K. & Wahl, G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540\u20132551 (1994).","journal-title":"Genes Dev."},{"key":"BFnm1000_1128_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/j.1460-2075.1993.tb05678.x","volume":"12","author":"Y Barak","year":"1993","unstructured":"Barak, Y., Juven, T., Haffner, R. & Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461\u2013468 (1993).","journal-title":"EMBO J."},{"key":"BFnm1000_1128_CR21","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott, F.J. et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001\u20135014 (1998).","journal-title":"EMBO J."},{"key":"BFnm1000_1128_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","volume":"395","author":"S Bates","year":"1998","unstructured":"Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124\u2013125 (1998).","journal-title":"Nature"},{"key":"BFnm1000_1128_CR23","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1101\/gad.12.15.2434","volume":"12","author":"E de Stanchina","year":"1998","unstructured":"de Stanchina, E. et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434\u20132442 (1998).","journal-title":"Genes Dev."},{"key":"BFnm1000_1128_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/8991","volume":"1","author":"JD Weber","year":"1999","unstructured":"Weber, J.D., Taylor, L.J., Roussel, M.F., Sherr, C.J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20\u201326 (1999).","journal-title":"Nature Cell Biol."},{"key":"BFnm1000_1128_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1097-2765(00)80351-2","volume":"3","author":"Y Zhang","year":"1999","unstructured":"Zhang, Y. & Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579\u2013591 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1000_1128_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/ijc.2910550428","volume":"55","author":"R Brown","year":"1993","unstructured":"Brown, R. et al. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int. J. Cancer 55, 678\u2013684 (1993).","journal-title":"Int. J. Cancer"},{"key":"BFnm1000_1128_CR27","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1038\/sj.onc.1202886","volume":"18","author":"WT Steegenga","year":"1999","unstructured":"Steegenga, W.T., Riteco, N. & Bos, J.L. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells. Oncogene 18, 5032\u20135043 (1999).","journal-title":"Oncogene"},{"key":"BFnm1000_1128_CR28","first-page":"2047","volume":"13","author":"N Billon","year":"1996","unstructured":"Billon, N., van Grunsven, L.A. & Rudkin, B.B. The CDK inhibitor p21WAF1\/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13, 2047\u20132054 (1996).","journal-title":"Oncogene"},{"key":"BFnm1000_1128_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/emboj\/17.2.554","volume":"17","author":"J Roth","year":"1998","unstructured":"Roth, J., Dobbelstein, M., Freedman, D.A., Shenk, T. & Levine, A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554\u2013564 (1998).","journal-title":"EMBO J."},{"key":"BFnm1000_1128_CR30","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1126\/science.272.5267.1470","volume":"272","author":"T Dobner","year":"1996","unstructured":"Dobner, T., Horikoshi, N., Rubenwolf, S. & Shenk, T. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470\u20131473 (1996).","journal-title":"Science"},{"key":"BFnm1000_1128_CR31","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1073\/pnas.96.12.6937","volume":"96","author":"W Tao","year":"1999","unstructured":"Tao, W. & Levine, A.J. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl Acad. Sci. USA 96, 6937\u20136941 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1000_1128_CR32","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","volume":"13","author":"CA Schmitt","year":"1999","unstructured":"Schmitt, C.A., McCurrach, M.E., de Stanchina, E., Wallace-Brodeur, R.R. & Lowe, S.W. INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670\u20132677 (1999).","journal-title":"Genes Dev."},{"key":"BFnm1000_1128_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/2057","volume":"4","author":"AR Hall","year":"1998","unstructured":"Hall, A.R., Dix, B.R., O'Carroll, S.J. & Braithwaite, A.W. p53-dependent cell death\/apoptosis is required for a productive adenovirus infection. Nature Med. 4, 1068\u20131072 (1998).","journal-title":"Nature Med."},{"key":"BFnm1000_1128_CR34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1128\/MCB.5.10.2552","volume":"5","author":"LE Babiss","year":"1985","unstructured":"Babiss, L.E., Ginsberg, H.S. & Darnell, J.E., Jr. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5, 2552\u20132558 (1985).","journal-title":"Mol. Cell. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1000_1128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1000_1128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1000_1128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:36:45Z","timestamp":1684453005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1000_1128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["BFnm1000_1128"],"URL":"https:\/\/doi.org\/10.1038\/80466","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}